Literature DB >> 17229401

Rosmarinic acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells.

Hwa Jung Lee1, Young-Il Jeong, Tae-Hyung Lee, In Duk Jung, Jun Sik Lee, Chang-Min Lee, Jong-Il Kim, Hwan Joo, Jae-Dong Lee, Yeong-Min Park.   

Abstract

Indoleamine 2,3-dioxygenase (IDO), a key enzyme that catalyses the initial and rate-limiting step in the degradation of the tryptophan, is simultaneously expressed in murine dendritic cells and macrophages stimulated with interferon-gamma (IFN-gamma). In the present study, we investigated whether rosmarinic acid (RA), which is suggested to exhibit anti-oxidant and anti-cyclooxygenase properties, could suppress the functional expression of IDO in murine bone marrow-derived dendritic cells (BMDCs) stimulated with IFN-gamma. Treatment with RA reduced intracellular expression of IDO both in IFN-gamma-activated BMDCs in vitro and in CD11c(+)CD8alpha(+) DCs in vivo tumor-bearing mice model. Consequently, we obtained evidence that RA suppresses the functional activity of IDO and blocks the IDO-dependent T cell suppression. In IFN-gamma-mediated induction of IDO transcription, activation of the signal transducer and activator of transcription 1 (STAT1) is important to be express IDO in IFN-gamma-stimulated BMDCs. In this study, we demonstrated that the RA could also suppress IFN-gamma-induced STAT1 activation. These novel findings provide a new insight into that RA as a pharmacological and transcriptional inhibitor of IDO is worthy of clinical application as well as further investigation for IDO regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17229401     DOI: 10.1016/j.bcp.2006.12.018

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

Review 1.  Dual protective role of HO-1 in transplanted liver grafts: a review of experimental and clinical studies.

Authors:  Chun-Feng Wang; Zhen-Yu Wang; Ji-Yu Li
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

2.  Anti-inflammatory Effects of Rosmarinic Acid in Lipopolysaccharide-Induced Mastitis in Mice.

Authors:  Kangfeng Jiang; Xiaofei Ma; Shuai Guo; Tao Zhang; Gan Zhao; Haichong Wu; Xiaoyan Wang; Ganzhen Deng
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

3.  Independent evolution of rosmarinic acid biosynthesis in two sister families under the Lamiids clade of flowering plants.

Authors:  Olesya Levsh; Tomáš Pluskal; Valentina Carballo; Andrew J Mitchell; Jing-Ke Weng
Journal:  J Biol Chem       Date:  2019-09-03       Impact factor: 5.157

4.  Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS.

Authors:  Thangavel Samikkannu; Kurapati V K Rao; Nimisha Gandhi; Shailendra K Saxena; Madhavan P N Nair
Journal:  J Neurovirol       Date:  2010-07       Impact factor: 2.643

5.  The cystine/glutamate antiporter regulates the functional expression of indoleamine 2,3-dioxygenase in human dendritic cells.

Authors:  J A D'Angelo; M L Mattox; E Fiebiger; B L Dickinson
Journal:  Scand J Immunol       Date:  2012-10       Impact factor: 3.487

6.  Differential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat protein.

Authors:  Thangavel Samikkannu; Zainulabedin M Saiyed; K V K Rao; Dakshayani Kadiyala Babu; Jose W Rodriguez; Marina N Papuashvili; Madhavan P N Nair
Journal:  AIDS Res Hum Retroviruses       Date:  2009-03       Impact factor: 2.205

Review 7.  T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.

Authors:  David J Kahler; Andrew L Mellor
Journal:  Handb Exp Pharmacol       Date:  2009

Review 8.  Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components.

Authors:  Wen-yu Wu; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

Review 9.  Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?

Authors:  Stefan Löb; Alfred Königsrainer; Hans-Georg Rammensee; Gerhard Opelz; Peter Terness
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

10.  Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.

Authors:  Vinod P Balachandran; Michael J Cavnar; Shan Zeng; Zubin M Bamboat; Lee M Ocuin; Hebroon Obaid; Eric C Sorenson; Rachel Popow; Charlotte Ariyan; Ferdinand Rossi; Peter Besmer; Tianhua Guo; Cristina R Antonescu; Takahiro Taguchi; Jianda Yuan; Jedd D Wolchok; James P Allison; Ronald P DeMatteo
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.